Vivan Therapeutics

Directions Website Contact the business

Vivan Therapeutics Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Vivan Therapeutics, Biotechnology company, The Westworks, White City Place, Unit 5, Part First Floor, 195 Wood Lane, London.

Vivan Therapeutics is a London based biotechnology company offering cancer patients access to the most advanced personalised cancer therapeutics based on technology pioneered at The Mount Sinai School of Medicine, New York.

13/11/2026

دراسة مستقبلية لتقييم نظام دعم القرار السريري المدعوم بالذكاء الاصطناعي لمرضى سرطان القولون والمستقيم، بهدف توفير أول بيانات في دولة الإمارات حول النتائج

A major milestone for Vivan Therapeutics 🎉Our TuMatch™ clinical registration study for colorectal cancer is set to begin...
12/11/2026

A major milestone for Vivan Therapeutics 🎉

Our TuMatch™ clinical registration study for colorectal cancer is set to begin at Burjeel Cancer Institute in Abu Dhabi. We’ve received all regulatory approvals, one of the first clearances in the Emirate for a study of this class of oncology software.

🔬 About the study
Led by Prof. Humaid Al Shamsi, the prospective study will:

Evaluate TuMatch™, our AI-powered clinical decision support software, in patients with colorectal cancer
Enrol at least 10 patients at the Abu Dhabi site
Generate the first UAE clinical outcomes and health-economics evidence for TuMatch™
🧬 How TuMatch™ works
It analyses a patient’s tumour genomic profile against Vivan’s proprietary drug-response dataset and published clinical evidence. The treating oncologist then gets a ranked set of treatment options based on that patient’s own tumour biology.

💬 “This approval takes TuMatch from a validated platform to a tool being used in live clinical decision-making. The evidence we generate will underpin our regulatory and reimbursement pathway well beyond the UAE.”
— Laura Towart, Founder & CEO

This study is part of our wider clinical programme. That programme includes a planned multicentre study in pancreatic and other GI cancers, with sites in Europe and the GCC, and will support our CE mark and FDA submissions.

🙏 Thank you to Prof. Humaid Al-Shamsi, Dr. Khaled Musallam, Rana Damsees and the Burjeel Cancer Institute team, and to Hub71 for supporting our growth in Abu Dhabi.

Not being treated in Abu Dhabi? Contact us to see if you’re eligible for TuMatch™ outside a clinical study (private pay). For fully bespoke guidance, our Personal Discovery Process (PDP) builds a live model of your tumour and screens thousands of cancer and non-cancer drugs against it to find the most effective treatment combinations.

🔗 Full press release and free consultation: link in bio
📧 [email protected]

Burjeel Hub71 Icahn School of Medicine at Mount Sinai Forbes Middle East Entrepreneur ME Department of Health, Abu Dhabi

How can your tumour’s genetics help guide your treatment options?Understanding your tumour’s genetic profile is the star...
21/10/2026

How can your tumour’s genetics help guide your treatment options?

Understanding your tumour’s genetic profile is the starting point. Turning that information into personalised treatment recommendations is where Vivan comes in.

We bring together tumour genetics, biological screening evidence and AI to identify personalised drug combinations for discussion with your oncologist.

How does it work?

🧬 TuMatch™ uses AI to analyse your tumour profile alongside Vivan’s proprietary screening data and publicly available data.

🔬 If there’s no suitable match yet, our Personal Discovery Process (PDP) creates a living model carrying your tumour’s mutations. We then screen thousands of drugs and combinations—including cancer drugs and drugs used to treat other conditions.

The results can help identify and rank standard treatment options, highlight relevant clinical trials, and uncover new combinations of existing drugs.

You and your oncologist receive a personalised report, with the evidence behind the recommendations, to support a more informed treatment discussion.

Swipe to see how it works →

Want to learn whether our services could be suitable for you or your patient? Get in touch—even if you haven’t had tumour genomic testing yet, we can guide you on the first steps.

Visit the link in our bio or send us a message.

Our Founder & CEO, Laura Towart, is attending the Abu Dhabi Future Health Summit 2026, 20–22 October at ADNEC Centre Abu...
19/10/2026

Our Founder & CEO, Laura Towart, is attending the Abu Dhabi Future Health Summit 2026, 20–22 October at ADNEC Centre Abu Dhabi.

This year’s theme, To Sense is to Predict, is central to what we’re building: an AI- and data-driven approach to precision oncology. TuMatch™, our AI-powered software tool, delivers ultra-personalised cancer treatment guidance based on each patient’s tumour profile.

Attending and want to meet Laura? DM us or email [email protected].

75 years after the Festival of Britain, it’s time for another future-facing moment, and we believe the future of cancer ...
07/10/2026

75 years after the Festival of Britain, it’s time for another future-facing moment, and we believe the future of cancer care is part of it.

We’re showcasing at Deep Tech London 🚀 Come and find our table on the expo floor to see how we’re using AI and one of the deepest proprietary datasets in oncology to personalise cancer treatment.

⏰ Thursday 8 October
📍 The Boiler House, Brick Lane
🎟️ Tickets: deeptech.london

Our Founder & CEO, Laura Towart, will be at the Abu Dhabi Future Health Summit, 20–22 October at ADNEC Centre.Vivan is a...
02/10/2026

Our Founder & CEO, Laura Towart, will be at the Abu Dhabi Future Health Summit, 20–22 October at ADNEC Centre.

Vivan is an AI and data-driven oncology biotech. Our proprietary dataset, one of the deepest in oncology, powers ultra-personalised cancer treatment guidance and AI-driven drug discovery.

Attending? Send us a DM to connect.

Future Health - A Global Initiative by Abu Dhabi

Today is   💙Around 1 in 4 people with colorectal cancer worldwide are diagnosed after the cancer has already spread.Ever...
30/09/2026

Today is 💙

Around 1 in 4 people with colorectal cancer worldwide are diagnosed after the cancer has already spread.

Every tumour is unique, so every treatment decision should be too.

TuMatch™, our AI-powered software tool, uses your tumour sequencing report to predict personalised treatment options for colorectal cancer, including combinations of cancer and non-cancer drugs.

Your first step: ask your oncologist about tumour sequencing.

If you’d like to find out if you have a TuMatch available, reach out to us at [email protected]

A huge thank you to the H&F Business Awards team for organising such a fantastic evening—and for selecting Vivan Therape...
21/09/2026

A huge thank you to the H&F Business Awards team for organising such a fantastic evening—and for selecting Vivan Therapeutics as a finalist for ‘STEM³ Business of the Year’. We were delighted to be part of it!

It was wonderful to celebrate alongside so many inspiring local businesses and meet the brilliant people behind them.

Hammersmith & Fulham Council Stephen Cowan 🇬🇧🇺🇦 Laura Towart

Today, we’re announcing a new discovery collaboration with Ad Atomica—bringing together Vivan’s genotype-resolved cancer...
16/09/2026

Today, we’re announcing a new discovery collaboration with Ad Atomica—bringing together Vivan’s genotype-resolved cancer screening data and Ad Atomica’s AI-driven molecule design platform to uncover new cancer drug candidates.

Vivan has generated more than 50 million tumour–drug datapoints through in vivo high-throughput screening of thousands of drugs and drug combinations. These data provide valuable insight into which therapies work against specific tumour genotypes.

Together, we will explore how these insights can be used to repurpose existing therapeutics and design new cancer drug candidates. The collaboration begins with an evaluation phase focused on identifying where genotype-informed design could generate promising candidates.

“We’re excited to partner with Ad Atomica. Their speed, design capability and commercial insight are exactly what we need to interrogate the data we have generated, unlock its value and turn it into real drug candidates.”
— Laura Towart, Founder and CEO of Vivan Therapeutics

We look forward to working with the Ad Atomica team to turn powerful biological insights into new possibilities for cancer drug discovery.

Read the full announcement via the link in our bio

Address

The Westworks, White City Place, Unit 5, Part First Floor, 195 Wood Lane
London
W127FQ

Alerts

Be the first to know and let us send you an email when Vivan Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Vivan Therapeutics:

Shortcuts

Sponsored

Share

Nearby engineering companies